Remedium Capital Partners, LLC VC / PE / Holdco

Location: Fort Lauderdale, FL

CIK: 0002104501 · Show all filings

Period: Q1 2026 (← Previous)

Filing Date: May 19, 2026

Total Value: $281M (100.0% shares, 0.0% debt)

Holdings (6)

Increased Positions (1)

GLTO Damora Therapeutics Inc 18.8%

Value $52.98M (+1811.2%) Shares 2,045,473 (+1597.9%) Est. Cost $25.31 Unrealized +2.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
GLTO	Damora Therapeutics Inc	2,045,473 (+1597.9%)	$52.98M (+1811.2%)	18.8%	$25.31	+2.0%	COM	36322Q206

Unchanged Positions (5)

ORKA Oruka Therapeutics Inc 27.3%

Value $76.8M Shares 1,565,661 Est. Cost $27.86 Unrealized +16.5%

SYRE Spyre Therapeutics Inc 26.1%

Value $73.45M Shares 1,456,231 Est. Cost $26.13 Unrealized +32.2%

APGE Apogee Therapeutics Inc 17.5%

Value $49.12M Shares 583,591 Est. Cost $62.99 Unrealized +14.7%

— Crescent Biopharma Inc 2.4%

Value $6.636M Shares 361,250 Est. Cost $11.86 Unrealized —

JBIO Jade Biosciences Inc 7.9%

Value $22.17M Shares 1,577,750 Est. Cost $11.73 Unrealized +26.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORKA	Oruka Therapeutics Inc	1,565,661	$76.8M	27.3%	$27.86	+16.5%	COM	687604108
SYRE	Spyre Therapeutics Inc	1,456,231	$73.45M	26.1%	$26.13	+32.2%	COM	00773J202
APGE	Apogee Therapeutics Inc	583,591	$49.12M	17.5%	$62.99	+14.7%	COM	03770N101
—	Crescent Biopharma Inc	361,250	$6.636M	2.4%	$11.86	—	COM	38000Q201
JBIO	Jade Biosciences Inc	1,577,750	$22.17M	7.9%	$11.73	+26.0%	COM	008064206